XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
MCPS [Member]
 [1]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2017 $ 18,745 $ 54 $ 3,631 $ 23,479 $ (3,803) $ (1,853) $ (4,149) $ 17,359 $ 1,386
Beginning balance, shares at Dec. 31, 2017   1,124              
Cumulative effect of new accounting standard         (5) 5      
Comprehensive income (loss) 1,330       1,120 113   1,233 97
Stock-based compensation expense 29     29       29  
Dividends to preferred shareholders 0   65 (65)       0  
Transactions with non-controlling interests (2)               (2)
Ending balance at Mar. 31, 2018 20,102 $ 54 3,696 23,443 (2,688) (1,735) (4,149) 18,621 1,481
Ending balance, shares at Mar. 31, 2018   1,124              
Beginning balance at Dec. 31, 2018 15,794 $ 56 $ 0 27,210 (5,958) (2,459) (4,142) 14,707 1,087
Beginning balance, shares at Dec. 31, 2018   1,196              
Comprehensive income (loss) (3)       (105) 100   (5) 2
Stock-based compensation expense 34     34       34  
Issuance of shares, value [2]                
Issuance of shares, shares   2              
Issuance of Treasury Shares 2     (3)     5 2  
Other (6)     (6)       (6)  
Ending balance at Mar. 31, 2019 $ 15,821 $ 56   $ 27,234 $ (6,063) $ (2,359) $ (4,137) $ 14,732 $ 1,089
Ending balance, shares at Mar. 31, 2019   1,198              
[1] Mandatory convertible preferred shares.
[2] Represents an amount less than $0.5 million.